N
Nocion Therapeutics
Developing novel treatments for silencing neurons
About Nocion Therapeutics
Nocion Therapeutics is a biotechnology company focused on developing novel small molecules, known as nocions, to treat conditions such as cough, itch, pain, and inflammation. These nocions specifically target activated sensory neurons, which are responsible for these symptoms, by entering through large pore channels that open in response to external insults. Once inside, nocions block all sodium channels, providing a targeted and sustained effect that traditional small molecule anesthetics cannot achieve. The company's platform is based on the well-understood physiology of nociceptors and aims to offer a more effective treatment for neurogenic inflammation compared to existing approaches. Nocion Therapeutics primarily serves the healthcare market, targeting patients suffering from conditions related to neurogenic inflammation. The business model involves the research and development of these specialized compounds, with revenue generated through partnerships, licensing agreements, and eventual product sales.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2024 | $62M | $248M | Osage University Partners · Canaan · F-Prime · Lumira Ventures | ↗ |
| EARLY VCOther financing | Aug 2021 | $7M | $28M | Undisclosed | — |
Growth signals
Latest recorded traffic for Nocion Therapeutics is 4.9K monthly website visits, up 36.1% over the last three months. Nocion Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nocion Therapeutics in the Needham ecosystem
The Nocion Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
Other known investors1 additional known investor
Harvard University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nocion Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nocion Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.


















